MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
- Status
- UNKNOWN
- Phase
- PHASE2
Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2